Cargando…
Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta‐analysis
BACKGROUND: Intralymphatic immunotherapy (ILIT) is a potential treatment option for allergic rhinitis (AR). We aimed to determine the efficacy (primary outcomes) and safety (secondary outcomes) of ILIT in treating patients with AR. METHODS: An electronic literature search was performed using MEDLINE...
Autores principales: | Aini, Nor Rahimah, Mohd Noor, Norhayati, Md Daud, Mohd Khairi, Wise, Sarah K., Abdullah, Baharudin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369948/ https://www.ncbi.nlm.nih.gov/pubmed/34429875 http://dx.doi.org/10.1002/clt2.12055 |
Ejemplares similares
-
Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis
por: Singh Randhawa, Aranjit, et al.
Publicado: (2022) -
Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis
por: Jiang, Sijie, et al.
Publicado: (2023) -
Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015) -
Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up
por: Adlany, Yasmin K., et al.
Publicado: (2022) -
The Clinical and Radiological Characterizations of the Allergic Phenotype of Chronic Rhinosinusitis with Nasal Polyps
por: Abdullah, Baharudin, et al.
Publicado: (2020)